2021
We classified non-demented European Prevention of Alzheimer’s Dementia (EPAD) participants through the amyloid/tau/neurodegeneration (ATN) scheme and assessed their neuropsychological and (…)
Consulter 
2021
Consulter
2021
Alzheimer disease (AD) is biologically defined by the presence of β-amyloid-containing plaques and tau-containing neurofibrillary tangles. AD is a genetic (…)
Consulter
2021
White matter hyperintensities (WMH) are often described in Alzheimer’s disease (AD), but their topography and specific relationships with cognition remain unclear.
Consulter
2021
Intracranial aneurysm (IA) is a frequent vascular malformation that can be managed by endovascular treatment (EVT) or microsurgery. A previously (…)
Consulter
2021
Studies supporting a strong association between tau deposition and neuronal loss, neurodegeneration, and cognitive decline have heightened the allure of (…)
Consulter
